Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-006832
Filing Date
2019-05-15
Accepted
2019-05-15 16:18:09
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fcsc-2019033110qx1.htm 10-Q 979284
2 EXHIBIT 31 fcsc-2019331ex31.htm EX-31 9869
3 EXHIBIT 32 fcsc-2019331ex32.htm EX-32 6933
10 fcsccolorlogoa12.jpg GRAPHIC 74382
11 pipelinegraph12312018a01.jpg GRAPHIC 58401
  Complete submission text file 0001628280-19-006832.txt   6670549

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fcsc-20190331.xml EX-101.INS 1314794
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20190331.xsd EX-101.SCH 53924
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20190331_cal.xml EX-101.CAL 66462
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20190331_def.xml EX-101.DEF 331147
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20190331_lab.xml EX-101.LAB 701408
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20190331_pre.xml EX-101.PRE 451792
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 19828447
SIC: 2834 Pharmaceutical Preparations